Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasms × Blood Specimen Collection × Other solid neoplasm × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Tumor-Agnostic 45 Gastrointestinal 14 Thoracic 9 Gynecologic 8 Genitourinary 8 Breast 8 Sarcoma 7 Head & Neck 5 Dermatologic 5 Other hematologic neoplasm 3 CNS 3 Lymphoid 2 Other solid neoplasm 1 Other 1

Conditions

Mesothelioma 3 Solid Tumor, Adult 2 Solid Tumor 2 Retinoblastoma 2 Thyroid Neoplasms 1 Thymus Neoplasms 1 Pneumothorax 1 Pleural Neoplasms 1 Pediatric Solid Tumor, Unspecified, Protocol Specific 1 Parathyroid Neoplasms 1 Neoplasms 1 Lung Neoplasms 1 Hemostatic Disorders 1 Carcinoma, Squamous Cell 1 Carcinoma, Non-Small-Cell Lung 1 Anatomic Stage III Breast Cancer AJCC v8 1 Advanced Solid Tumor 1 Adenocarcinoma 1

Interventions

pembrolizumab 4 Cisplatin 3 Carboplatin 3 budigalimab 2 Pemetrexed 2 Paclitaxel 2 Immunotherapy 2 Etoposide 2 Drug Therapy 2 Docetaxel 2 Cyclophosphamide 2 venetoclax 1 trametinib 1 spartalizumab 1 sargramostim 1 rovalpituzumab tesirine 1 ribociclib 1 poly ICLC 1 fludarabine 1 enzalutamide 1 entinostat 1 belinostat 1 UV1 vaccine 1 Thrombopoietin 1 Sunitinib 1 Sirolimus 1 Quality of Life 1 Polymerase Chain Reaction 1 Patient Reported Outcome Measures 1 PM 01183 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04164134 2023-07-25

NIRBTEST

Amsterdam UMC, location VUmc

Other solid neoplasm

Neoplasms, Retinoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡